
doi: 10.1586/erc.12.136
pmid: 23244363
Atrial fibrillation (AF) is currently the most commonly treated cardiac arrhythmia. It is generally a progressive disease, often more difficult to control as electromechanical remodeling alters the underlying substrate. Patients typically evolve from infrequent, self-terminating episodes, to more frequent and sustained events. In addition, atrial remodeling may make sinus rhythm more challenging to achieve. Although an ablation strategy limited to pulmonary vein isolation may be curative in those with paroxysmal AF, a more extensive approach is often required in those with persistent AF. This article discusses the current approaches and most recent advances in the ablation of persistent and long-standing persistent AF.
Evidence-Based Medicine, Drug Resistance, Anticoagulants, Combined Modality Therapy, Postoperative Complications, Pulmonary Veins, Atrial Fibrillation, Catheter Ablation, Disease Progression, Secondary Prevention, Humans, Heart Atria, Precision Medicine, Anti-Arrhythmia Agents
Evidence-Based Medicine, Drug Resistance, Anticoagulants, Combined Modality Therapy, Postoperative Complications, Pulmonary Veins, Atrial Fibrillation, Catheter Ablation, Disease Progression, Secondary Prevention, Humans, Heart Atria, Precision Medicine, Anti-Arrhythmia Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
